Despite its promising start, Vigora 50 mg faced several challenges in its early years. Regulatory approvals were a significant hurdle, requiring rigorous clinical trials to establish its safety and efficacy. Additionally, the stigma associated with erectile dysfunction and its treatment posed marketing challenges. To overcome these obstacles, Zydus Cadila invested heavily in educational campaigns to DE stigmatize ED and promote open conversations about sexual health. These efforts, coupled with strategic marketing, helped Vigora gain acceptance and establish a strong market presence. Over the years, advancements in pharmaceutical technology have significantly impacted the development and refinement of Vigora 50 mg.

https://www.flatmeds.com/product/vigora-50-mg/